This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Kyoto Prefectural Public University Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mari Dezawa: Inventor in Regenerative Medicine.
Introduction
Mari Dezawa is an inventor associated with Sendai, Japan, whose patent work concerns a potential cell-based treatment for peripheral blood flow disorders. Her listed patent record includes 1 patent.
Latest Patents
The patent titled “Therapeutic Agent of Peripheral Blood Flow Disorder” describes a cell product containing SSEA-3-positive pluripotent stem cells, also known as Muse cells. These cells may be derived from mesenchymal tissue in a living body or from cultured mesenchymal cells. The proposed use is to treat peripheral blood flow disorders, particularly peripheral arterial disease and, more specifically, chronic arterial obstruction in a limb.
Career Highlights
The supplied information associates Dezawa with Kyoto Prefectural Public University Corporation and Masaaki Kitada. These affiliations provide context for her professional and research connections.
Collaborations
Her listed coworkers include Satoaki Matoba and Yoshinori Fujiyoshi, reflecting connections with researchers in her professional network.
Conclusion
Mari Dezawa’s patent work focuses on the potential therapeutic use of Muse cells for peripheral blood flow disorders, including chronic arterial obstruction in a limb.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile